PBM Polytex Ltd
- Market Cap ₹ 39.2 Cr.
- Current Price ₹ 57.0
- High / Low ₹ 104 / 51.8
- Stock P/E
- Book Value ₹ 167
- Dividend Yield 0.00 %
- ROCE -6.15 %
- ROE -5.22 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.34 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.62% over past five years.
- Company has a low return on equity of -4.39% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Textiles Textiles & Apparels Other Textile Products
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 232 | 217 | 192 | 179 | 197 | 211 | 171 | 154 | 255 | 202 | 192 | 176 | 174 | |
| 197 | 196 | 178 | 168 | 189 | 204 | 171 | 148 | 223 | 201 | 200 | 180 | 178 | |
| Operating Profit | 35 | 21 | 15 | 11 | 8 | 7 | -0 | 6 | 32 | 2 | -9 | -4 | -4 |
| OPM % | 15% | 10% | 8% | 6% | 4% | 3% | -0% | 4% | 13% | 1% | -4% | -2% | -2% |
| 4 | 3 | 3 | 6 | 2 | 4 | 3 | 2 | 3 | 3 | 4 | 2 | 2 | |
| Interest | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 6 | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 30 | 17 | 11 | 13 | 6 | 7 | -2 | 4 | 31 | 1 | -8 | -6 | -6 |
| Tax % | 34% | 37% | 39% | 23% | -13% | 35% | -84% | 27% | 26% | 46% | -25% | -26% | |
| 20 | 11 | 7 | 10 | 7 | 5 | -0 | 3 | 23 | 0 | -6 | -5 | -5 | |
| EPS in Rs | 24.23 | 13.03 | 8.31 | 12.10 | 8.78 | 5.62 | -0.39 | 4.56 | 33.44 | 0.44 | -9.16 | -6.80 | -6.59 |
| Dividend Payout % | 10% | 46% | 36% | 25% | 40% | 11% | 0% | 33% | 12% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 1% |
| 3 Years: | -12% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -55% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 2% |
| 3 Years: | -21% |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 2% |
| 3 Years: | -4% |
| Last Year: | -5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 84 | 88 | 92 | 98 | 103 | 104 | 95 | 99 | 121 | 120 | 114 | 110 | 108 |
| 27 | 21 | 12 | 16 | 8 | 15 | 1 | 0 | 1 | 1 | 1 | 0 | 4 | |
| 24 | 28 | 29 | 26 | 19 | 20 | 22 | 30 | 32 | 20 | 25 | 15 | 14 | |
| Total Liabilities | 143 | 145 | 141 | 148 | 138 | 148 | 125 | 136 | 161 | 147 | 147 | 132 | 132 |
| 62 | 60 | 58 | 55 | 54 | 53 | 51 | 48 | 50 | 52 | 54 | 52 | 52 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| Investments | 5 | 24 | 24 | 20 | 14 | 33 | 13 | 3 | 4 | 5 | 12 | 5 | 38 |
| 75 | 60 | 59 | 72 | 70 | 61 | 62 | 85 | 106 | 91 | 80 | 75 | 42 | |
| Total Assets | 143 | 145 | 141 | 148 | 138 | 148 | 125 | 136 | 161 | 147 | 147 | 132 | 132 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 | 32 | 16 | -1 | 4 | 23 | 2 | -2 | 4 | 23 | -11 | -6 | |
| -8 | -21 | -1 | 5 | 6 | -24 | 19 | 10 | -5 | -3 | -9 | 7 | |
| -24 | -9 | -15 | -1 | -12 | 3 | -26 | -1 | -2 | -3 | 0 | -2 | |
| Net Cash Flow | -3 | 2 | 0 | 3 | -2 | 2 | -5 | 7 | -2 | 17 | -20 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 13 | 11 | 18 | 14 | 24 | 21 | 24 | 20 | 32 | 18 | 30 |
| Inventory Days | 161 | 118 | 143 | 177 | 155 | 102 | 153 | 236 | 175 | 96 | 148 | 142 |
| Days Payable | 13 | 15 | 21 | 22 | 11 | 11 | 26 | 10 | 33 | 10 | 6 | 11 |
| Cash Conversion Cycle | 159 | 116 | 133 | 173 | 158 | 115 | 148 | 249 | 163 | 119 | 160 | 161 |
| Working Capital Days | 79 | 46 | 58 | 76 | 88 | 47 | 92 | 120 | 101 | 90 | 103 | 120 |
| ROCE % | 27% | 16% | 10% | 10% | 6% | 5% | -2% | 4% | 27% | -1% | -8% | -6% |
Documents
Announcements
-
Disclosure Received From Promoter-Shareholder For Intent To Sale Of Shares Of The Company
1d - Promoter intends to sell 6,457 shares in open market, estimated value Rs.35 Lakh; intimation dated 12/12/2025.
-
Disclosure Received From Promoter-Shareholder For Intent To Sale Of Shares Of The Company
1d - Promoter intends to sell shares in open market; estimated value Rs.35 lakh; dated 12/12/2025.
-
Announcement under Regulation 30 (LODR)-Credit Rating
29 Nov - CARE retained CARE BBB long-term; outlook changed Stable→Negative; short-term CARE A3+ unchanged, announced 29-Nov-2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Publication of Unaudited Financial Results for the QE 30.09.2025 in the English and Gujarati Newspaper on 15.11.2025
- Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025 14 Nov
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company is a part of the Patodia family. It manufactures 100% cotton yarn which is sold domestically and in export market.